Back

Partnering with Prescribers: The Role of Medication in CSC for Early Psychosis

11:30am - August 26, 2022 thru 1:00pm - August 26, 2022 | Timezone: US/Eastern
New England MHTTC
Registration Deadline: August 26, 2022
Need more information?
Contact us at [email protected]

This talk will review the team-based approach to medication management in early psychosis treatment, including the role of non-prescribers in supporting positive health behaviors for patients experiencing early-course psychosis. The speakers will present recent updates in our understanding of psychiatry for early-course psychosis and lead a discussion on medication management with two individuals with lived experience of psychosis. We welcome attendees to submit Q&A questions beforehand here: https://forms.gle/F4DSQW9dWEHi8W6z8

 

Matcheri Keshavan, MD is the Stanley Cobb Professor and Academic Head of the Harvard Department of Psychiatry at Beth Israel Deaconess Medical Center. He has conducted early psychosis intervention and research for nearly three decades, and has published over 600 papers and 4 books on psychotic and related disorders. He edits the Elsevier journal Schizophrenia Research and is on the editorial Board of several other journals, including the Journal of Early Intervention in Psychiatry.

 

Dr. Schooler is Professor of Psychiatry and Behavioral Sciences at State University of New York Downstate Health Sciences Center, New York, NY.  She is a fellow of the American College of Neuropsychopharmacology, the Collegium Internationale Neuropsychopharmacologicum (CINP), the American Psychological Association, and the American Psychological Society.  Dr. Schooler has been President of the American Psychopathological Association and the Association for Clinical Psychosocial Research, an elected Councilor of the CINP and a member of the SIRS Board of Directors.

 

Charles Stromeyer works in stocks investing, advising startup companies, & doing research in artificial intelligence. He has helped with pioneering multiple industries such as AI- based programmatic marketing, the intercloud & deep learning- based software coding assistants, & the startups he helped have since raised more than $6 billion in funding. He was awarded the Deval L. Patrick Commonwealth Innovation Award. Charles is also a member of the Consumer Advisory Board (or CAB) at the at the Psychosis Research Program of the MMHC Public Psychiatry Division of Beth Israel Deaconess Medical Center, Boston, MA. His hobbies include music, movies & neurobiology, and he especially enjoys mentoring young people, including 14 individuals in the Forbes 30 Under 30 lists. 

 

Nate Schwirian is also a member of the CAB at MMHC. He has an interdisciplinary Bachelor of Arts degree from UMass Amherst and an Associate of Science degree in Biotechnology from MassBay Community College. He currently works with Tunefoolery Music (a group of musicians in mental health recovery), where he works as an audio technician, performer, and meditation group facilitator. 

 


 

This webinar is part of an initiative by the Substance Abuse and Mental Health Services Administration (SAMHSA)’s New England Mental Health Technology Transfer Center Network (MHTTC), which provides training, technical assistance, and tool and resource development to enable states and mental health practitioners to provide recovery-oriented practices within the context of recovery-oriented systems of care (see https://mhttcnetwork.org/centers/new-england-mhttc/home).

 

This webinar will be co-hosted by the Massachusetts Psychosis Network for Early Treatment (MAPNET, www.mapnet.online).